Clinical trial
Pentoxifylline/Nonalcoholic Steatohepatitis (NASH) Study: The Effect of…
NCT00267670 · Northwestern University, Other · Completed
Key facts
| NCT number | NCT00267670 |
|---|---|
| Title | Pentoxifylline/Nonalcoholic Steatohepatitis (NASH) Study: The Effect of Pentoxifylline on NASH |
| Official title | The Effect of Pentoxifylline on Nonalcoholic Steatohepatitis (NASH) |
| Lead sponsor | Northwestern University, Other |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Nonalcoholic Steatohepatitis, Liver Diseases |
| Intervention type | Drug |
| Interventions | Pentoxifylline, Placebo |
| Enrollment | 26 |
| Start date | Mar 1, 2005 |
| Primary completion | Sep 1, 2009 |
| Completion | Sep 1, 2009 |
| First posted | Dec 21, 2005 |
| Last update posted | Sep 9, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: